The effects of chronic oxotremorine treatment on spatial learning and tolerance development in mice

J M Wehner1, M Upchurch

  • 1Institute for Behavioral Genetics, University of Colorado, Boulder 80309.

Insights

Oxotremorine treatment in mice caused tolerance and reduced muscarinic receptors. However, spatial learning deficits resolved before tolerance fully disappeared, suggesting dissociation between receptor loss and cognitive impairment.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Oxotremorine is a muscarinic acetylcholine receptor agonist.
  • Tolerance to drug effects and associated neurochemical changes are common.
  • Investigating the relationship between receptor changes and behavioral deficits is crucial.

Purpose of the Study:

  • To investigate the time course of tolerance to oxotremorine.
  • To examine the recovery of muscarinic receptors after oxotremorine treatment.
  • To assess the impact of oxotremorine on spatial learning and its recovery.

Main Methods:

  • C57BL mice received continuous oxotremorine infusion.
  • Tolerance was assessed via body temperature and rotarod performance.
  • Muscarinic receptor binding (3H-QNB) and Morris water task were used.

Main Results:

  • Significant tolerance to oxotremorine developed after 6 days of treatment.
  • Muscarinic receptor binding was reduced across multiple brain regions.
  • Spatial learning deficits were observed one day after treatment cessation but resolved by two days.

Conclusions:

  • Tolerance to oxotremorine and muscarinic receptor loss are dissociable.
  • Spatial learning deficits recover faster than tolerance.
  • These findings suggest distinct mechanisms underlying tolerance and cognitive impairment.

Related Concept Videos